| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... Nature cancer 2 (12), 1305-1320, 2021 | 158 | 2021 |
| A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis N Joharatnam, DF McWilliams, D Wilson, M Wheeler, I Pande, DA Walsh Arthritis research & therapy 17, 1-9, 2015 | 136 | 2015 |
| Challenges in the treatment of gastric cancer in the older patient N Joharatnam-Hogan, KK Shiu, K Khan Cancer treatment reviews 85, 101980, 2020 | 101 | 2020 |
| Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2 L Au, A Fendler, STC Shepherd, K Rzeniewicz, M Cerrone, F Byrne, ... Nature Medicine 27 (8), 1362-1366, 2021 | 84 | 2021 |
| Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial N Joharatnam-Hogan, F Cafferty, R Hubner, D Swinson, S Sothi, K Gupta, ... The lancet Gastroenterology & hepatology 4 (11), 854-862, 2019 | 60 | 2019 |
| Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study A Fendler, L Au, STC Shepherd, F Byrne, M Cerrone, LA Boos, ... Nature Cancer 2 (12), 1321-1337, 2021 | 57 | 2021 |
| <? covid19?> Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience N Joharatnam-Hogan, D Hochhauser, KK Shiu, H Rush, V Crolley, ... Therapeutic advances in medical oncology 12, 1758835920956803, 2020 | 41 | 2020 |
| Interpretation of DAS28 and its components in the assessment of inflammatory and non-inflammatory aspects of rheumatoid arthritis DF McWilliams, PDW Kiely, A Young, N Joharatnam, D Wilson, DA Walsh BMC rheumatology 2, 1-12, 2018 | 39 | 2018 |
| Statins as potential chemoprevention or therapeutic agents in cancer: a model for evaluating repurposed drugs N Joharatnam-Hogan, L Alexandre, J Yarmolinsky, B Lake, N Capps, ... Current Oncology Reports 23, 1-13, 2021 | 29 | 2021 |
| A guideline for the outpatient management of glycaemic control in people with cancer N Joharatnam‐Hogan, P Chambers, K Dhatariya, R Board, ... Diabetic Medicine 39 (1), e14636, 2022 | 17 | 2022 |
| COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study VE Crolley, D Hanna, N Joharatnam-Hogan, N Chopra, E Bamac, ... Therapeutic advances in medical oncology 12, 1758835920971147, 2020 | 17 | 2020 |
| Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study. Nat Cancer 2021 A Fendler, STC Shepherd, L Au, KA Wilkinson, M Wu, F Byrne, M Cerrone, ... DOI: https://doi. org/10.1038/s43018-021-00274-w, 1305-1320, 0 | 15 | |
| Multimodal treatment in metastatic colorectal cancer (mCRC) improves outcomes—the University College London Hospital (UCLH) experience N Joharatnam-Hogan, W Wilson, KK Shiu, GK Fusai, B Davidson, ... Cancers 12 (12), 3545, 2020 | 13 | 2020 |
| 1557O Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study STC Shepherd, A Fendler, L Au, F Byrne, K Wilkinson, M Wu, AM Schmitt, ... Annals of Oncology 32, S1129, 2021 | 12 | 2021 |
| Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial N Joharatnam-Hogan, D Hatem, FH Cafferty, G Petrucci, DA Cameron, ... British Journal of Cancer 129 (4), 706-720, 2023 | 11 | 2023 |
| Establishment of CORONET, COVID-19 risk in oncology evaluation tool, to identify patients with cancer at low versus high risk of severe complications of COVID-19 disease on … RJ Lee, O Wysocki, C Zhou, R Shotton, A Tivey, L Lever, J Woodcock, ... JCO clinical cancer informatics 6, e2100177, 2022 | 11 | 2022 |
| Testing approaches to sharing trial results with participants: The Show RESPECT cluster randomised, factorial, mixed methods trial A South, N Joharatnam-Hogan, C Purvis, EC James, C Diaz-Montana, ... PLoS medicine 18 (10), e1003798, 2021 | 11 | 2021 |
| The role of aspirin in the prevention of ovarian, endometrial and cervical cancers N Joharatnam-Hogan, FH Cafferty, A Macnair, A Ring, RE Langley Women's Health 16, 1745506520961710, 2020 | 10 | 2020 |
| Diabetes and cancer: Optimising glycaemic control N Joharatnam‐Hogan, DL Morganstein Journal of Human Nutrition and Dietetics 36 (2), 504-513, 2023 | 7 | 2023 |
| Joint British Diabetes Society for Inpatient Care (JBDS), UK Chemotherapy Board (UKCB). A guideline for the outpatient management of glycaemic control in people with cancer N Joharatnam-Hogan, P Chambers, K Dhatariya Diabet Med 39 (1), e14636, 2022 | 7 | 2022 |
